BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
So I will split the dose of cis-platinum and it's more tolerable. And that's what they did in this trial. And I really like that.
0
💬
0
Comments
Log in to comment.
There are no comments yet.